Showing results (191-200 of 1,059) with videos related to
Sort By:
Pageof 106
Alzheimer'S & Dementia (New York, N. Y.)|December 22, 2025
Electroencephalography-based signatures of cognitive resilience in individuals with stable mild cognitive impairment despite carrying a high-risk for progression to dementiaChiara Pappalettera, Lorenzo Nucci, Alessia Cacciotti, et al.Alzheimer'S & Dementia (New York, N. Y.)|November 3, 2025
Omics-derived biological modules reflect tau positron emission tomography in Alzheimer's diseaseSi-Chun Gu, Qiao Yang Sun, Hui-Qin Liu, et al.Alzheimer'S & Dementia (New York, N. Y.)|June 25, 2025
A splice-switching antisense oligonucleotide targeting APP reduces accumulation of α-synuclein in a mouse model of Parkinson's diseaseRijwan U Ahammad, Brian Spencer, Bao Quach, et al.Alzheimer'S & Dementia (New York, N. Y.)|July 16, 2025
Cardiorespiratory fitness modifies the relationship between arterial stiffness and cerebral blood flow independent of physical activityBrianne M Breidenbach, Ira Driscoll, Matthew P Glittenberg, et al.Alzheimer'S & Dementia (New York, N. Y.)|June 23, 2025
System readiness and the patient care pathway for Alzheimer's disease diagnosis and treatmentB Joy Snider, Alessandro Biffi, Sasha Bozeat, et al.Alzheimer'S & Dementia (New York, N. Y.)|October 10, 2025
Simulation of Alzheimer's diagnostic flows with blood biomarker test options in JapanAtaru Igarashi, Noriyuki Kimura, Takuya Ataka, et al.Alzheimer'S & Dementia (New York, N. Y.)|May 16, 2025
How do we put meaning into meaningful benefit? Perspectives from the lived experienceRuss Paulsen, Carla DeMuro Romano, Terry Frangiosa, et al.Alzheimer'S & Dementia (New York, N. Y.)|May 15, 2025
Incorporating individually defined brain health priorities in clinical trial outcomes: the electronic Person-Specific Outcome Measure approach in the United StatesStina Saunders, Ali Jannati, Shane Sheehan, et al.Alzheimer'S & Dementia (New York, N. Y.)|May 20, 2025
Correction to Vietnamese Insights into Cognitive Aging Program (VIP): Objectives, study design, and cohort descriptionAlzheimer'S & Dementia (New York, N. Y.)|July 11, 2025
Correction to "The HOPE4MCI study: AGB101 treatment slows progression of entorhinal cortex atrophy in APOE ε4 non-carriers with mild cognitive impairment due to Alzheimer's disease"Pageof 106